Done right, portfolio management is where value originates. Great portfolio managers are able to create and maximize value as fluently as any leading scientist. However, are you confident you and your company are able to define, measure and realize value in early development phases every single time?
Any executive with responsibility for their company’s pipeline will benefit from a new multi-perspective panel discussion we are assembling. Assessment of value has shifted hugely amongst payers, patients and physicians in the past few years and will only accelerate. We’re going to help you better understand how to get real impact from your R&D and Licensing resources. The exclusive panel will help you understand:
You can't make it? Sign up for free and I will send you the recording.
Senior Partner. PureTech, Former President, Global R&D
Pfizer
Vice President, Decision Support Group
AbbVie
Former Head of Portfolio Management and Business Intelligence Systems
Merck
President, DZA, Former SVP, Global Scientific Strategy - Portfolio Management
Merck
Vice President
Equinox Group
Managing Director
Biotech MedPartners